Skip to main content

Site notifications

Notice for pemigatinib (Incyte Biosciences Australia Pty Ltd)

Active ingredients
pemigatinib
Date of review outcome
Lapse date
Type
Provisional approval
Therapeutic area
Oncology

Help us improve this page